Lanean...
PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
Poly(ADP-ribose) polymerases have shown true promise in early clinical studies due to reported activity in BRCA-associated cancers. PARP inhibitors may represent a potentially important new class of chemotherapeutic agents directed at targeting cancers with defective DNA-damage repair. In order to w...
Gorde:
| Argitaratua izan da: | Prz Menopauzalny |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Termedia Publishing House
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327624/ https://ncbi.nlm.nih.gov/pubmed/28250726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pm.2016.65667 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|